UNC-Chapel Hill, Duke to be awarded up to $50 million from the FDA for new research center
July 11, 2023 Triangle CERSI will work with FDA scientists to perform cutting edge scientific research to better inform and support the FDA’s needs.
The Abstract: July 10, 2023
July 10, 2023 New research from biostatistics, health behavior and nutrition, plus a new grant to study lung cancer screening.
The Abstract: June 12, 2023
June 12, 2023 New biostatistics awards and research for Garcia and Montoya, a new book from a nutrition alumna, and a list of honors for Gillings researchers.
New study reveals strong connection between heart and brain health
June 1, 2023 Biostatistics researchers at UNC have collaborated on research that sheds light on the close relationship between cardiovascular diseases and brain diseases, unraveling the underlying genetic signatures and inter-organ connections between the heart and brain.
The Abstract: May 15, 2023
May 15, 2023 New publications from Rozier, Montoya and researchers from the Department of Maternal and Child Health.
New research uncovers link between neurodegenerative disease and changes in brain shape
April 14, 2023 New research from UNC and Florida State University demonstrates how neurodegenerative diseases, such as Alzheimer’s disease, can significantly accelerate changes in subcortical areas of the brain in older adults.
Bivalent COVID-19 boosters effectively protect against new omicron subvariants
April 12, 2023 New research led by the Gillings School shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.
Gillings study shows updated bivalent boosters are more effective at preventing hospitalization and death from omicron
January 25, 2023 Researchers at the Gillings School found that bivalent boosters are more effective than original monovalent boosters at preventing COVID-19-related hospitalization and death, according to a new study in The New England Journal of Medicine.
UNC pancreatic cancer therapy studies backed by 5-year, $10.9 million NIH SPORE grant
October 20, 2022 The National Cancer Institute has awarded UNC researchers $10.9 million in funding to further enhance treatment solutions for pancreatic cancer by focusing on key challenges to identifying, producing and directing new therapies.
COVID-19 vaccines, boosters and prior infection provide durable protection against severe outcomes of infection
September 27, 2022 A new JAMA study of more than 10 million North Carolinians highlights just how effective COVID-19 vaccines, boosters and prior infection can be, both in reducing the risk of future infection and in preventing hospitalization and death.
